Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Releases

71732 Press Releases
DateTitleCompany
05 Apr 12 GenMark and Advanced Liquid Logic Enter into Agreement to Develop an All-Electronic Fully Integrated Diagnostic Platform GenMark Diagnostics Inc.,
Published by
Business Wire
05 Apr 12 Tecan granted patent for revolutionary NanoQuant Plate™ Tecan
05 Apr 12 New Data to Show Viral Cure Rates in the Most Difficult to Treat Hepatitis C Patients Boehringer Ingelheim,
Published by
Business Wire
05 Apr 12 Axxess Technology Solutions is the Fastest Growing Home Health Software Platform in the Industry VOCUS,
Published by
PR Newswire
05 Apr 12 AB SCIEX and Phenomenex Develop Food Safety Solution for India AB SCIEX,
Published by
Business Wire
05 Apr 12 AHF: AIDS Patients Protest, Testify Against Ohio Plan to Ration AIDS Drugs AIDS Healthcare Foundation,
Published by
Business Wire
05 Apr 12 Covidien Announces Definitive Agreement to Acquire Oridion Systems Ltd. Covidien,
Published by
Business Wire
05 Apr 12 OPKO Health Acquires Chilean Pharmaceutical Company OPKO Health Inc.,
Published by
Business Wire
05 Apr 12 Novel Prostate Nanomedicine Delivers High Drug Concentration Directly and Safely to Tumors in Phase I Trials Prostate Cancer Foundation,
Published by
Business Wire
05 Apr 12 Cannabis Science Reports Second Cancer Patient Receives Clean Biopsy Report Confirming the Biopsy is Free of Cancer Cells Cannabis Science Inc.,
Published by
Business Wire
05 Apr 12 Molecular Partners Comments on Allergan’s Progress in Phase IIa Retinal Disease Trial Using Anti-VEGF DARPin® Molecular Partners AG,
Published by
Business Wire
05 Apr 12 BIND Biosciences Publishes Data on BIND-014, the First Targeted and Programmable Nanomedicine to Show Clinical Anti-Tumor Effects BIND Biosciences,
Published by
Business Wire
04 Apr 12 IntegraGen Launches ARISk™ Test, a Genetic Screening Tool for Autism in High-Risk Children IntegraGen,
Published by
Business Wire
04 Apr 12 Red Cross Helping Texans Recover After Tornadoes AMERICAN RED CROSS NATIONAL HEADQUARTERS,
Published by
PR Newswire
04 Apr 12 Inspra®(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF <30% Pfizer,
Published by
Ketchum Pleon Limited
04 Apr 12 Bristol-Myers Squibb to Present New Data Demonstrating Company’s Commitment to Research and Development in Liver Disease at The International Liver CongressTM / European Association for the Study of the Liver (EASL) Annual Meeting Bristol-Myers Squibb Company,
Published by
Business Wire
04 Apr 12 Research and Markets: Global Pharmaceuticals, Biotechnology & Life Sciences Research and Markets,
Published by
Business Wire
04 Apr 12 Encouraging Selumetinib Results Announced for Phase 2 Trial in Ovarian Cancer Array BioPharma Inc.,
Published by
Business Wire
04 Apr 12 BASF and Catalent Join Forces to Solve Bioavailability Challenges Catalent Pharma Solutions,
Published by
Business Wire
04 Apr 12 Synta Announces Results on Ganetespib Across a Range of Malignancies at the American Association for Cancer Research (AACR) Annual Meeting Synta Pharmaceuticals Corp.,
Published by
Business Wire
04 Apr 12 Phase 2 Clinical Trial Results: VEN100 Reduces Antibiotic-Associated Diarrhea by 50% in High-Risk Patients Ventria Bioscience,
Published by
Business Wire
04 Apr 12 Mannatech Presents Glyconutrient Science at the 10th Jenner Glycobiology and Medicine Symposium Mannatech Incorporated,
Published by
Business Wire
04 Apr 12 Patient Access to Premium-Priced Targeted Cancer Treatments in Brazil and Mexico is Improving, Creating an Opportunity for Developers of EGFR Inhibitors Burlington Mass. Decision Resources,
Published by
Business Wire
04 Apr 12 BIND Biosciences Presents Clinical Data on BIND-014 Promising Anti-tumor Effects in Patients with Advanced or Metastatic Cancers BIND Biosciences,
Published by
Business Wire
04 Apr 12 Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, April 25, 2012 Thermo Fisher Scientific Inc.,
Published by
Business Wire
04 Apr 12 Breakthrough Treatments, Fewer Doctor Office Visits, Reduced Use of Medicines Impact U.S. Healthcare in 2011, According to IMS Study IMS Institute for Healthcare Informatics,
Published by
Business Wire
04 Apr 12 Inspra®?(eplerenone) now Approved for Reduction of Risk for Cardiovascular Morbidity and Mortality in Adult Patients with Chronic Heart Failure (NYHA Class II) and LVEF <30% Pfizer,
Published by
Ketchum Pleon Limited
04 Apr 12 PREMIER Biosoft Awarded for its Exemplary Contribution Towards Corporate Social Responsibility PREMIER Biosoft
04 Apr 12 American Diabetes Association to Collaborate with Quintiles’ Digital Patient Unit Quintiles,
Published by
Business Wire
04 Apr 12 MDA Awards $120,000 to Catabasis Pharmaceuticals Catabasis Pharmaceuticals,
Published by
Business Wire
Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.